QQ客服 官方微博 反馈留言

	Abraxane (R) versus Taxol (R) for patients with advanced breast cancer: A prospective time and motion analysis from a Chinese health care perspective
	Dranitsaris, George; Yu, Bo; Wang, Leiping; Sun, Weili; Zhou, Yan; King, Jennifer; Kaura, Satyin; Zhang, Adams; Yuan, Peng
	2016
卷号	22期号:2页码:205-211
关键词	Abraxane (R) paclitaxel metastatic breast cancer resource use cost analysis
ISSN号	1078-1552
DOI	10.1177/1078155214556008
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6382880
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Dranitsaris, George,Yu, Bo,Wang, Leiping,et al. Abraxane (R) versus Taxol (R) for patients with advanced breast cancer: A prospective time and motion analysis from a Chinese health care perspective[J],2016,22(2):205-211.
APA	Dranitsaris, George.,Yu, Bo.,Wang, Leiping.,Sun, Weili.,Zhou, Yan.,...&Yuan, Peng.(2016).Abraxane (R) versus Taxol (R) for patients with advanced breast cancer: A prospective time and motion analysis from a Chinese health care perspective.,22(2),205-211.
MLA	Dranitsaris, George,et al."Abraxane (R) versus Taxol (R) for patients with advanced breast cancer: A prospective time and motion analysis from a Chinese health care perspective".22.2(2016):205-211.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。